- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Biomarkers in Epilepsy
Authors
Keywords
HLA, Sodium channels, Side effect, Prognosis, Pharmaco-resistance, Pharmaco-response
Journal
Neurotherapeutics
Volume 11, Issue 2, Pages 324-333
Publisher
Springer Nature
Online
2014-02-25
DOI
10.1007/s13311-014-0262-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs
- (2014) Karolina M. Stępień et al. Pharmacological Reports
- Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A
- (2013) Dalia Kasperavičiūtė et al. BRAIN
- HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
- (2013) Ying-Kit Cheung et al. EPILEPSIA
- Mutations inPRRT2are not a common cause of infantile epileptic encephalopathies
- (2013) Sarah E. Heron et al. EPILEPSIA
- Epilepsy biomarkers
- (2013) Jerome Engel et al. EPILEPSIA
- Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models
- (2013) Haruka Nakanishi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PRRT2-related disorders: further PKD and ICCA cases and review of the literature
- (2013) Felicitas Becker et al. JOURNAL OF NEUROLOGY
- P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
- (2013) Maria Feldmann et al. LANCET NEUROLOGY
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy
- (2013) Carlos A. Twardowschy et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- PRRT2 Mutations Cause Benign Familial Infantile Epilepsy and Infantile Convulsions with Choreoathetosis Syndrome
- (2012) Sarah E. Heron et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Glucose transporter 1 deficiency in the idiopathic generalized epilepsies
- (2012) Todor Arsov et al. ANNALS OF NEUROLOGY
- Epileptic encephalopathies (including severe epilepsy syndromes)
- (2012) Athanasios Covanis EPILEPSIA
- Enzyme induction with antiepileptic drugs: Cause for concern?
- (2012) Martin J. Brodie et al. EPILEPSIA
- Homozygous c.649dupC mutation inPRRT2worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences
- (2012) Angelo Labate et al. EPILEPSIA
- Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32
- (2012) et al. HUMAN MOLECULAR GENETICS
- PRRT2 Mutations are the major cause of benign familial infantile seizures
- (2012) Julian Schubert et al. HUMAN MUTATION
- Ion channels in genetic and acquired forms of epilepsy
- (2012) Holger Lerche et al. JOURNAL OF PHYSIOLOGY-LONDON
- Adverse effects of antiepileptic drugs
- (2012) Piero Perucca et al. LANCET NEUROLOGY
- GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy
- (2012) P. Striano et al. NEUROLOGY
- Patterns of treatment response in newly diagnosed epilepsy
- (2012) M. J. Brodie et al. NEUROLOGY
- Effects of polymorphisms in six candidate genes on phenytoin maintenance therapy in Han Chinese patients
- (2012) Chin-Chuan Hung et al. PHARMACOGENOMICS
- Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
- (2012) Mark McCormack et al. PHARMACOGENOMICS
- Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy
- (2012) Mila Lovrić et al. THERAPEUTIC DRUG MONITORING
- Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions
- (2012) Hsien-Yang Lee et al. Cell Reports
- Pharmacogenomics: a key component of personalized therapy
- (2012) Matthias Schwab et al. Genome Medicine
- Cerebral expression of drug transporters in epilepsy
- (2011) Eleonora Aronica et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport
- (2011) Heidrun Potschka ADVANCED DRUG DELIVERY REVIEWS
- KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
- (2011) Sarah Weckhuysen et al. ANNALS OF NEUROLOGY
- Drug Transporters in Drug Efficacy and Toxicity
- (2011) M.K. DeGorter et al. Annual Review of Pharmacology and Toxicology
- Omics and Drug Response
- (2011) Urs A. Meyer et al. Annual Review of Pharmacology and Toxicology
- Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
- (2011) Douglas B. Kell et al. DRUG DISCOVERY TODAY
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Deep sequencing reveals 50 novel genes for recessive cognitive disorders
- (2011) Hossein Najmabadi et al. NATURE
- Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia
- (2011) Wan-Jin Chen et al. NATURE GENETICS
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
- (2011) Elke Schaeffeler et al. Genome Medicine
- Cerebral white matter recovery in abstinent alcoholics—a multimodality magnetic resonance study
- (2010) Stefan Gazdzinski et al. BRAIN
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population
- (2010) Dong-Mei An et al. EPILEPSY RESEARCH
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Efficacy Loss of the Anticonvulsant Carbamazepine in Mice Lacking Sodium Channel Subunits via Paradoxical Effects on Persistent Sodium Currents
- (2010) M. Uebachs et al. JOURNAL OF NEUROSCIENCE
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain
- (2010) Y. Liao et al. NEUROLOGY
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
- (2010) Tracy A. Glauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- KV7 channelopathies
- (2010) Snezana Maljevic et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: A systematic review and meta-analysis
- (2010) B.S. Haerian et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1
- (2009) Arvid Suls et al. ANNALS OF NEUROLOGY
- Genetic Variants in Microsomal Epoxide Hydrolase Influence Carbamazepine Dosing
- (2009) Mohd Makmor-Bakry et al. CLINICAL NEUROPHARMACOLOGY
- Genetic mechanisms in idiopathic epilepsies
- (2009) Yvonne G Weber et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: A meta-analysis
- (2009) Facundo Garcia Bournissen et al. EPILEPSIA
- Clinical spectrum ofSCN1Amutations
- (2009) Antonio Gambardella et al. EPILEPSIA
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- CYP2C9*1B Promoter Polymorphisms, in Linkage with CYP2C19*2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose
- (2009) A. S. Chaudhry et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- De novo mutations of voltage-gated sodium channel II gene SCN2A in intractable epilepsies
- (2009) I. Ogiwara et al. NEUROLOGY
- Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1
- (2008) A. Suls et al. BRAIN
- A functional polymorphism in theSCN1Agene is not associated with carbamazepine dosages in Austrian patients with epilepsy
- (2008) EPILEPSIA
- The clinical impact of pharmacogenetics on the treatment of epilepsy
- (2008) Wolfgang Löscher et al. EPILEPSIA
- Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs
- (2008) Anne T Nies et al. Expert Opinion on Drug Metabolism & Toxicology
- The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood–brain barrier in patients with generalized epilepsy
- (2008) Silvio Basic et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started